JP2023539344A5 - - Google Patents
Info
- Publication number
- JP2023539344A5 JP2023539344A5 JP2023514081A JP2023514081A JP2023539344A5 JP 2023539344 A5 JP2023539344 A5 JP 2023539344A5 JP 2023514081 A JP2023514081 A JP 2023514081A JP 2023514081 A JP2023514081 A JP 2023514081A JP 2023539344 A5 JP2023539344 A5 JP 2023539344A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063073140P | 2020-09-01 | 2020-09-01 | |
| US63/073,140 | 2020-09-01 | ||
| PCT/US2021/048127 WO2022051198A1 (en) | 2020-09-01 | 2021-08-30 | Combination of cabotegravir and levonorgestrel |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023539344A JP2023539344A (ja) | 2023-09-13 |
| JP2023539344A5 true JP2023539344A5 (https=) | 2024-09-06 |
| JPWO2022051198A5 JPWO2022051198A5 (https=) | 2024-09-06 |
Family
ID=77897768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023514081A Pending JP2023539344A (ja) | 2020-09-01 | 2021-08-30 | カボテグラビルおよびレボノルゲストレルの組合せ |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20230321089A1 (https=) |
| EP (1) | EP4208169A1 (https=) |
| JP (1) | JP2023539344A (https=) |
| WO (1) | WO2022051198A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025068743A1 (en) * | 2023-09-27 | 2025-04-03 | ViiV Healthcare UK (No.3) Limited | Pharmaceutical composition of cabotegravir |
| CN121909019A (zh) * | 2023-09-27 | 2026-04-21 | Viiv保健英国第三有限公司 | 药物组合物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8129385B2 (en) | 2005-04-28 | 2012-03-06 | Shionogi & Co., Ltd. | Substituted 5-hydroxy-3,4,6,9,9a, 10-hexanhydro-2h-1-oxa04a,8a-diaza-anthracene-6,10-dioness |
| TWI577377B (zh) | 2010-09-16 | 2017-04-11 | Ｖｉｉｖ醫療保健公司 | 醫藥組合物 |
| UY38982A (es) | 2019-12-09 | 2021-06-30 | Viiv Healthcare Co | Composiciones farmacéuticas |
-
2021
- 2021-08-30 WO PCT/US2021/048127 patent/WO2022051198A1/en not_active Ceased
- 2021-08-30 EP EP21773974.7A patent/EP4208169A1/en active Pending
- 2021-08-30 US US18/042,485 patent/US20230321089A1/en active Pending
- 2021-08-30 JP JP2023514081A patent/JP2023539344A/ja active Pending